Dapagliflozin-d4

(Synonyms: BMS-512148-d4)

Dapagliflozin-d4 (BMS-512148-d4) is deuterium labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine. Dapagliflozin induces HIF1 expression and attenuates renal IR injury.

For research use only. We do not sell to patients.

  • CAS No.: 1224234-25-6
  • Formula: C21H21D4ClO6
  • Molecular Weight:412.90
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All SGLT Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00